mRNA Cancer Vaccine Cuts Melanoma Recurrence by 49%
A personalized mRNA cancer vaccine paired with Keytruda cut melanoma recurrence and death risk by 49% over 5 years, new trial data shows.
mRNA Cancer Vaccine Cuts Melanoma Recurrence by 49% Read More »